| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Alex P. Hamilton is Director at MGRX and has filed Form 4s across 2 companies. Alex P. Hamilton's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $22K at current prices.
Historically, Alex P. Hamilton's trades have earned a strong insider score of 78/100 across 4 rated trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +60.5%.
The biggest single holding is MGRX (~$22K) as Director. The MGRX filings lean toward selling, a net 250,000 shares.
Alex P. Hamilton has 8 Form 4 filings on record from June 2024 to July 2026, across 2 companies: Director at Mangoceuticals (MGRX), 2024–2026; Director at Addentax Group (ATXG), 2025.
The 9 reported transactions were 5 stock awards and 4 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $205K.
The largest open-market sale was 125,000 shares of MGRX at an average $1.22 on November 19, 2025, about $153K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 | MGRX Mangoceuticals, Inc. | Director | Sell | 125,000 | $1.22 | $152,875.00 | -97.4% | -69.4% | - | |
| Sep 8, 2025 | ATXG Addentax Group Corp. | Director | Sell | 23,095 | $0.52 | $12,009.40 | -100% | -16.1% | -56.6% | |
| Jun 26, 2024 | MGRX Mangoceuticals, Inc. | Director | Sell | 125,000 | $0.32 | $39,834.26 | -71.4% | -28.8% | -63.6% |